Senior insider sale
Chief Executive Officer at DAY ONE BIOPHARMACEUTICALS, INC. — senior position signals high conviction
$250.4K
31.95K shares
What this filing means
BENDER JEREMY plans to sell 31.95K shares of DAY ONE BIOPHARMACEUTICALS, INC. valued at approximately $250.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/17/2025ACC: 0001950047-25-008926
DirectorOfficer· Chief Executive Officer
Since May 2021
31.95K
Shares to sell
$250.4K
Approx. market value
15.89K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
11/15/2025
15.89KTotal acquired15.89K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/15/2025 | Restricted Stock Not Applicable | 15.89K | — |
| Total | 15.89K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
16.06K
Market value
$108.7K
8/18/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
15.89K
Market value
$141.7K
11/17/2025
Total
Units
31.95K
Value
$250.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/18/2025 | 16.06K | $108.7K | — | Completed |
| Planned — Approximate Date | ||||
11/17/2025 | 15.89K | $141.7K | NASDAQ | Planned |
| Total | 31.95K | $250.4K | ||